试验的初级预期目标是降低肿瘤进展的危险程度。
The primary endpoint of the trial was to reduce the risk of tumour progression.
统计甲状腺切除术后与肿瘤进展相关的危险因素。
Factors associated with disease progression following thyroid surgery have been calculated.
凋亡抑制因子在肿瘤进展中的作用日益受到人们的关注。
We are attracted by the function of inhibitor of apoptosis in carcinoma progression.
而且，甲状腺切除术后与肿瘤进展相关的危险因素迄今为止并不确定。
Also, risk factors associated with disease progression following thyroidectomy are not yet defined.
这个事实与肿瘤存在于应激环境和衰老可能是肿瘤进展的一个有效的抑制的概念相符。
This fact is consistent with the concept that tumors are stressful environments and that senescence can be an efficient brake on tumor progression.
结论：VEGF与口腔癌肿瘤血管生成密切相关，VEGF阳性分级可作为反映肿瘤进展的一项指标。
Classification of VEGF positive rate may be used as an index reflecting progression of oral carcinoma.
摘要肿瘤的化学预防，即应用天然的、合成的或者生物化学因子逆转、抑制或阻止肿瘤进展为浸润性肿瘤。
Cancer chemoprevention is defined as the use of natural, synthetic, or biologic chemical agents to reverse, suppress, or prevent carcinogenic progression to invasive cancer.
观察有效率(RR)、临床受益率(CBR)、肿瘤进展时间(TTP)、生活质量(QOL)及不良反应。
The response rate (RR), the clinical benefit rate (CBR), time of tumor progression (TTP) and the quality of life (QOL) were observed.
本文综述具有科学证据支持并与肿瘤进展相关的肿瘤干细胞模型，同时探讨该模型的在实验应用和临床治疗的价值。
In this review we present scientific evidence supporting the cancer stem cell model of tumor progression, and discuss the experimental and therapeutic implications.
结论：HIFU能够控制肿瘤进展，改善胰腺癌患者生活质量，可下调血清vegf表达水平，干预血管生成，不良反应轻微。
Conclusions: HIFU can control tumor development, improve quality of patients' life. It can suppress angiogenesis by decreasing levels of serum VEGF, and is of little adverse reaction.
周期素d 1编码一种全酶的调节亚单位，该酶利用蛋白磷酸化灭活视网膜母细胞瘤蛋白，通过细胞周期G 1 - S期促进肿瘤进展恶化。
Cyclin D1 encodes the regulatory subunit of a holoenzyme that phosphorylates and inactivates the retinoblastoma protein and promotes progression through the G1-S phase of the cell cycle.
结论CD 4 +CD 25 + T细胞在胃癌患者中比例升高，可能是产生肿瘤免疫抑制的重要机制，CD 4 + CD 25 + T细胞的高表达可作为胃癌患者肿瘤进展的重要标志。
Conclusion: the increase in the relative prevalence of CD4 + CD25 + tr may be responsible of the mechanism of immune suppression and tumor progression in gastric cancer patients.
有时候这是有益的，因为这些靶点同样参与肿瘤的进展。
Sometimes this is favorable, as these targets can also be involved in tumor development. In other cases, increasing the dose only leads to an increase in side effects.8, 9, 10.
多数的专家认为这得益于“无进展生存”，阿瓦斯丁已经被许多肿瘤学家作为“未贴签”药物用于治疗，足以完全通过审批。
Most scientific experts consider this benefit "progression-free survival," sufficient for full approval, and many oncologists have been using Avastin as an "off-label" drug for this purpose.
预后不良与大肿瘤相关可能主要是由于进展为远处转移的风险。
The poor prognosis associated with large tumors may be due to the risk of developing distant metastases.
事实如此，比如对于有微小的胰腺损害以及慢性胰腺炎的患者，他们需要排除患有进展性的肿瘤。
This is the case, for instance, with patients with small pancreatic lesions and those with chronic pancreatitis in whom the development of cancer must be ruled out.
文章主要介绍了几个治疗核素标记抗体在肿瘤治疗方面的应用与进展。
The application and evolution of several therapy nuclides labelled antibody in tumour therapy are introduced.
对很多患者，索坦可以延缓或阻止肿瘤的进展，并帮助消退肿瘤。
For many patients, SUTENT may slow or stop the growth of cancer and may help to shrink tumors.
国际肝病：你能谈一下原发性非hcc肿瘤肝移植最新的进展以及移植的适应症吗？
Hepatology Digest: Can you talk a little bit about some of the latest progress for liver transplantation for primary non-HCC tumors including some of the indications for transplant?
错构瘤是肿块的杂乱无章，但有区别的，细胞，而在案件TSC很少进展，以恶性肿瘤。
Hamartomas are lumps of disorganized, but differentiated, cells, which in the case of TSC rarely progress to malignancy.
随着所有基因组测序的重要进展，我们有时可能忘记，分子肿瘤学家数十年来一直忙于揭示肿瘤在分子水平是如何发生的。
With all the important advances in genomic sequencing, one can sometimes forget that molecular oncologists have been busy for decades to uncover what happens at the molecular level in oncogenesis.
血栓栓塞性疾病是恶性肿瘤疾病过程中常见的并发症，其存在与肿瘤本身的进展、治疗及预后密切相关。
Thromboembolism disease is a frequent complication of malignant tumor, which is closely associated with the progression, therapy and prognosis of cancer.
现就近年来肿瘤淋巴管生成与转移的研究进展作一综述。
In recent years, is now on the tumor lymphangiogenesis and the transfer of the research are reviewed.
端粒—端粒酶系统在肿瘤细胞的恶性进展和永生细胞的维护中起重要作用。
The telomere and telomerase play an important role in the malignant progress of tumor cells and the maintenance of immortal cell lines.
这是接受化疗或造血干细胞移植（HSCT）血液恶性肿瘤患者抗真菌治疗的重大进展。
This represents a major advance for antifungal therapy in haematological malignancy patients undergoing chemotherapy or haematopoietic stem cell transplant (HSCT).
下面就硫氧还蛋白系统的结构特点、功能，硫氧还蛋白系统与肿瘤的关系等研究进展作一综述。
This review provides a summary of advances about the structure, function of thioredoxin and the relationship between thioredoxin and tumors.
虽然现代肿瘤综合治疗方面已取得相当进展，但作为一种常见肿瘤，其预后仍不容乐观。
Although comprehensive treatments in modern oncology have made rapid progress, but as one common tumor, patients' prognosis still remains very poor.
虽然现代肿瘤综合治疗方面已取得相当进展，但作为一种常见肿瘤，其预后仍不容乐观。
Although comprehensive treatments in modern oncology have made rapid progress, but as one common tumor, patients' prognosis still remains very poor.
应用推荐